[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Eye Drug-China Market Status and Trend Report 2013-2023

February 2018 | 149 pages | ID: ECB73F7849FEN
MIReports Co., Limited

US$ 2,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Eye Drug-China Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Eye Drug industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole China and Regional Market Size of Eye Drug 2013-2017, and development forecast 2018-2023
Main market players of Eye Drug in China, with company and product introduction, position in the Eye Drug market
Market status and development trend of Eye Drug by types and applications
Cost and profit status of Eye Drug, and marketing status
Market growth drivers and challenges

The report segments the China Eye Drug market as:

China Eye Drug Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

North China
Northeast China
East China
Central & South China
Southwest China
Northwest China

China Eye Drug Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Drops
Tablet & Capsule

China Eye Drug Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Glaucoma
Retinal Disease
Bacterial Infection
Other

China Eye Drug Market: Players Segment Analysis (Company and Product introduction, Eye Drug Sales Volume, Revenue, Price and Gross Margin):

Pfizer
Novartis
bausch Lomb
Laboratoire Riva
Jamp Pharma
Fresenius
Teva Pharmaceutical
SANDOZ
Greenstone
Mylan
GE Medical
Mint Pharmaceuticals
Laboratoires Thea
Taj Pharmaceuticals
Actavis
APOTEX
Sun Pharma

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

CHAPTER 1 OVERVIEW OF EYE DRUG

1.1 Definition of Eye Drug in This Report
1.2 Commercial Types of Eye Drug
  1.2.1 Drops
  1.2.2 Tablet & Capsule
1.3 Downstream Application of Eye Drug
  1.3.1 Glaucoma
  1.3.2 Retinal Disease
  1.3.3 Bacterial Infection
  1.3.4 Other
1.4 Development History of Eye Drug
1.5 Market Status and Trend of Eye Drug 2013-2023
  1.5.1 China Eye Drug Market Status and Trend 2013-2023
  1.5.2 Regional Eye Drug Market Status and Trend 2013-2023

CHAPTER 2 CHINA MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Eye Drug in China 2013-2017
2.2 Consumption Market of Eye Drug in China by Regions
  2.2.1 Consumption Volume of Eye Drug in China by Regions
  2.2.2 Revenue of Eye Drug in China by Regions
2.3 Market Analysis of Eye Drug in China by Regions
  2.3.1 Market Analysis of Eye Drug in North China 2013-2017
  2.3.2 Market Analysis of Eye Drug in Northeast China 2013-2017
  2.3.3 Market Analysis of Eye Drug in East China 2013-2017
  2.3.4 Market Analysis of Eye Drug in Central & South China 2013-2017
  2.3.5 Market Analysis of Eye Drug in Southwest China 2013-2017
  2.3.6 Market Analysis of Eye Drug in Northwest China 2013-2017
2.4 Market Development Forecast of Eye Drug in China 2018-2023
  2.4.1 Market Development Forecast of Eye Drug in China 2018-2023
  2.4.2 Market Development Forecast of Eye Drug by Regions 2018-2023

CHAPTER 3 CHINA MARKET STATUS AND FORECAST BY TYPES

3.1 Whole China Market Status by Types
  3.1.1 Consumption Volume of Eye Drug in China by Types
  3.1.2 Revenue of Eye Drug in China by Types
3.2 China Market Status by Types in Major Countries
  3.2.1 Market Status by Types in North China
  3.2.2 Market Status by Types in Northeast China
  3.2.3 Market Status by Types in East China
  3.2.4 Market Status by Types in Central & South China
  3.2.5 Market Status by Types in Southwest China
  3.2.6 Market Status by Types in Northwest China
3.3 Market Forecast of Eye Drug in China by Types

CHAPTER 4 CHINA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Eye Drug in China by Downstream Industry
4.2 Demand Volume of Eye Drug by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Eye Drug by Downstream Industry in North China
  4.2.2 Demand Volume of Eye Drug by Downstream Industry in Northeast China
  4.2.3 Demand Volume of Eye Drug by Downstream Industry in East China
  4.2.4 Demand Volume of Eye Drug by Downstream Industry in Central & South China
  4.2.5 Demand Volume of Eye Drug by Downstream Industry in Southwest China
  4.2.6 Demand Volume of Eye Drug by Downstream Industry in Northwest China
4.3 Market Forecast of Eye Drug in China by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF EYE DRUG

5.1 China Economy Situation and Trend Overview
5.2 Eye Drug Downstream Industry Situation and Trend Overview

CHAPTER 6 EYE DRUG MARKET COMPETITION STATUS BY MAJOR PLAYERS IN CHINA

6.1 Sales Volume of Eye Drug in China by Major Players
6.2 Revenue of Eye Drug in China by Major Players
6.3 Basic Information of Eye Drug by Major Players
  6.3.1 Headquarters Location and Established Time of Eye Drug Major Players
  6.3.2 Employees and Revenue Level of Eye Drug Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 EYE DRUG MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Pfizer
  7.1.1 Company profile
  7.1.2 Representative Eye Drug Product
  7.1.3 Eye Drug Sales, Revenue, Price and Gross Margin of Pfizer
7.2 Novartis
  7.2.1 Company profile
  7.2.2 Representative Eye Drug Product
  7.2.3 Eye Drug Sales, Revenue, Price and Gross Margin of Novartis
7.3 bausch Lomb
  7.3.1 Company profile
  7.3.2 Representative Eye Drug Product
  7.3.3 Eye Drug Sales, Revenue, Price and Gross Margin of bausch Lomb
7.4 Laboratoire Riva
  7.4.1 Company profile
  7.4.2 Representative Eye Drug Product
  7.4.3 Eye Drug Sales, Revenue, Price and Gross Margin of Laboratoire Riva
7.5 Jamp Pharma
  7.5.1 Company profile
  7.5.2 Representative Eye Drug Product
  7.5.3 Eye Drug Sales, Revenue, Price and Gross Margin of Jamp Pharma
7.6 Fresenius
  7.6.1 Company profile
  7.6.2 Representative Eye Drug Product
  7.6.3 Eye Drug Sales, Revenue, Price and Gross Margin of Fresenius
7.7 Teva Pharmaceutical
  7.7.1 Company profile
  7.7.2 Representative Eye Drug Product
  7.7.3 Eye Drug Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical
7.8 SANDOZ
  7.8.1 Company profile
  7.8.2 Representative Eye Drug Product
  7.8.3 Eye Drug Sales, Revenue, Price and Gross Margin of SANDOZ
7.9 Greenstone
  7.9.1 Company profile
  7.9.2 Representative Eye Drug Product
  7.9.3 Eye Drug Sales, Revenue, Price and Gross Margin of Greenstone
7.10 Mylan
  7.10.1 Company profile
  7.10.2 Representative Eye Drug Product
  7.10.3 Eye Drug Sales, Revenue, Price and Gross Margin of Mylan
7.11 GE Medical
  7.11.1 Company profile
  7.11.2 Representative Eye Drug Product
  7.11.3 Eye Drug Sales, Revenue, Price and Gross Margin of GE Medical
7.12 Mint Pharmaceuticals
  7.12.1 Company profile
  7.12.2 Representative Eye Drug Product
  7.12.3 Eye Drug Sales, Revenue, Price and Gross Margin of Mint Pharmaceuticals
7.13 Laboratoires Thea
  7.13.1 Company profile
  7.13.2 Representative Eye Drug Product
  7.13.3 Eye Drug Sales, Revenue, Price and Gross Margin of Laboratoires Thea
7.14 Taj Pharmaceuticals
  7.14.1 Company profile
  7.14.2 Representative Eye Drug Product
  7.14.3 Eye Drug Sales, Revenue, Price and Gross Margin of Taj Pharmaceuticals
7.15 Actavis
  7.15.1 Company profile
  7.15.2 Representative Eye Drug Product
  7.15.3 Eye Drug Sales, Revenue, Price and Gross Margin of Actavis
7.16 APOTEX
7.17 Sun Pharma

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF EYE DRUG

8.1 Industry Chain of Eye Drug
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF EYE DRUG

9.1 Cost Structure Analysis of Eye Drug
9.2 Raw Materials Cost Analysis of Eye Drug
9.3 Labor Cost Analysis of Eye Drug
9.4 Manufacturing Expenses Analysis of Eye Drug

CHAPTER 10 MARKETING STATUS ANALYSIS OF EYE DRUG

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications